CIDEX OPA CONCENTRATE DIN 02278340
Status: Cancelled Post Market
Holder: JOHNSON & JOHNSON MEDTECH, A DIVISION OF JOHNSON & JOHNSON (CANADA) INC.
Molecule: ORTHO-PHTHALALDEHYDE
Health Canada record
| Active ingredient(s) | ORTHO-PHTHALALDEHYDE 5.75 % |
|---|---|
| Dosage form | Solution |
| Route | Disinfectant (Medical Instruments) |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Disinfectant |
| ATC | V07AV TECHNICAL DISINFECTANTS |
| Original market date | 07-Nov-2007 |
| Current status date | 25-Jul-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Johnson & Johnson MedTech, a division of Johnson & Johnson (Canada) Inc. — licence 100200, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ORTHO-PHTHALALDEHYDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02239732 | CIDEX OPA SOLUTION | JOHNSON & JOHNSON MEDTECH, A DIVISION OF JOHNSON & JOHNSON (CANADA) INC. | Solution | ORTHO-PHTHALALDEHYDE 0.55 % | Cancelled Post Market |
| 02414333 | RAPICIDE OPA/28 HIGH LEVEL DISINFECTANT | MEDIVATORS INC | Liquid | ORTHO-PHTHALALDEHYDE 0.575 % | Cancelled Post Market |